New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- 380 Interlocken Crescent
- Suite 780
- Broomfield AL, 80021
- UNITED STATES
Accera is a privately-held, commercial-stage, healthcare company focused on the discovery, development and in-licensing of innovative therapeutics to treat Central Nervous System (CNS) disorders.